106 related articles for article (PubMed ID: 11561874)
1. Influence of a complementary treatment with oral enzymes on patients with colorectal cancers--an epidemiological retrolective cohort study.
Popiela T; Kulig J; Hanisch J; Bock PR
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S55-63. PubMed ID: 11561874
[TBL] [Abstract][Full Text] [Related]
2. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study.
Beuth J; Ost B; Pakdaman A; Rethfeldt E; Bock PR; Hanisch J; Schneider B
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S45-54. PubMed ID: 11561873
[TBL] [Abstract][Full Text] [Related]
3. Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma.
Sakalová A; Bock PR; Dedík L; Hanisch J; Schiess W; Gazová S; Chabronová I; Holomanova D; Mistrík M; Hrubisko M
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S38-44. PubMed ID: 11561871
[TBL] [Abstract][Full Text] [Related]
4. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.
Schumacher K; Schneider B; Reich G; Stiefel T; Stoll G; Bock PR; Hanisch J; Beuth J
Anticancer Res; 2003; 23(6D):5081-7. PubMed ID: 14981970
[TBL] [Abstract][Full Text] [Related]
5. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects.
Dale PS; Tamhankar CP; George D; Daftary GV
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S29-34. PubMed ID: 11561869
[TBL] [Abstract][Full Text] [Related]
6. [Comparative epidemiological study in patients with rheumatic diseases illustrated in a example of a treatment with non-steroidal anti- inflammatory drugs versus an oral enzyme combination preparation].
Wittenborg A; Bock PR; Hanisch J; Saller R; Schneider B
Arzneimittelforschung; 2000 Aug; 50(8):728-38. PubMed ID: 10994157
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.
Gujral MS; Patnaik PM; Kaul R; Parikh HK; Conradt C; Tamhankar CP; Daftary GV
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S23-8. PubMed ID: 11561868
[TBL] [Abstract][Full Text] [Related]
8. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
11. Enzyme therapy in patients with advanced colorectal cancer.
Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
Przegl Lek; 2000; 57 Suppl 5():138-9. PubMed ID: 11202278
[No Abstract] [Full Text] [Related]
12. Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer.
Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
Przegl Lek; 2000; 57 Suppl 5():142. PubMed ID: 11202281
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.
Dörr W; Herrmann T;
Strahlenther Onkol; 2007 Mar; 183(3):121-7. PubMed ID: 17340069
[TBL] [Abstract][Full Text] [Related]
14. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany.
Vollbracht C; Schneider B; Leendert V; Weiss G; Auerbach L; Beuth J
In Vivo; 2011; 25(6):983-90. PubMed ID: 22021693
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
Kato T; Ohashi Y; Nakazato H; Koike A; Saji S; Suzuki H; Takagi H; Nimura Y; Hasumi A; Baba S; Manabe T; Maruta M; Miura K; Yamaguchi A
Langenbecks Arch Surg; 2002 Mar; 386(8):575-81. PubMed ID: 11914933
[TBL] [Abstract][Full Text] [Related]
16. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
17. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Sørensen F; Bone J; Jacobsen NO; Sell A; Overgaard J; Bertelsen K
Br J Cancer; 1992 Jan; 65(1):102-7. PubMed ID: 1733432
[TBL] [Abstract][Full Text] [Related]
18. [Use of WOBE-MUGOS E for prevention and correction of experimental doxorubicin side-effects].
Todor IN; Solianik GI; Iurchenko OV; Shpilevaia SI; Luk'ianova NIu; Trindiak VP; Kunskaia LN; Ponomareva OV; Terzov AI; Kulik GI; Chekhun VF
Lik Sprava; 2001; (3):116-21. PubMed ID: 11559997
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
20. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial.
Martin T; Uhder K; Kurek R; Roeddiger S; Schneider L; Vogt HG; Heyd R; Zamboglou N
Radiother Oncol; 2002 Oct; 65(1):17-22. PubMed ID: 12413670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
